Clinical Nuclear Medicine 1981-06-01

Tumor detection with 1-aminocyclopentane and 1-aminocyclobutane C-11-carboxylic acid using positron emission computerized tomography.

K F Hübner, S Krauss, L C Washburn, W D Gibbs, E C Holloway

Index: Clin. Nucl. Med. 6(6) , 249-52, (1981)

Full Text: HTML

Abstract

Eight patients with proven or suspected neoplastic lesions were examined with 1-aminocyclobutane C-11-carboxylic acid and 1-aminocyclopentane C-11-carboxylic acid using positron emission computed tomography. The results of this comparative study have shown that both of these unnatural amino acids have a high affinity for malignant tumors. The potential of nonmetabolizable C-11-labeled amino acids as noninvasive indicators of metabolic tumor activity is demonstrated and discussed.


Related Compounds

Related Articles:

[Change in the level of 1-aminochloropropane-1-carbonic acid. Activity of a protein inhibitor of polygalacturonase, intensity of formation of oligouronides in apples during ripening and treatment with haloethane derivatives and aminoethoxyvinylglycine].

2003-01-01

[Prikl. Biokhim. Mikrobiol. 39(4) , 461-4, (2003)]

Glycine antagonist action of 1-aminocyclobutane-1-carboxylate (ACBC) in Xenopus oocytes injected with rat brain mRNA.

1989-08-22

[Eur. J. Pharmacol. 167(2) , 291-4, (1989)]

Ethylene biosynthesis: processing of a substrate analog supports a radical mechanism for the ethylene-forming enzyme.

1998-01-01

[Chem. Biol. 5(1) , 49-57, (1998)]

Dietary N-3 fatty acids inhibit ischaemic and excitotoxic brain damage in the rat.

1993-01-01

[Brain Res. Bull. 32(3) , 223-6, (1993)]

1-aminocyclobutane[11C]carboxylic acid, a potential tumor-seeking agent.

1979-10-01

[J. Nucl. Med. 20(10) , 1055-61, (1979)]

More Articles...